These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10619673)

  • 1. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
    Soma CE; Dubernet C; Bentolila D; Benita S; Couvreur P
    Biomaterials; 2000 Jan; 21(1):1-7. PubMed ID: 10619673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
    de Verdière AC; Dubernet C; Némati F; Soma E; Appel M; Ferté J; Bernard S; Puisieux F; Couvreur P
    Br J Cancer; 1997; 76(2):198-205. PubMed ID: 9231919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
    Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.
    Soma CE; Dubernet C; Barratt G; Nemati F; Appel M; Benita S; Couvreur P
    Pharm Res; 1999 Nov; 16(11):1710-6. PubMed ID: 10571276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
    Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclosporin to isohexylcyanoacrylate nanospheres and subsequent release in human plasma in vitro.
    Bonduelle S; Foucher C; Leroux JC; Chouinard F; Cadieux C; Lenaerts V
    J Microencapsul; 1992; 9(2):173-82. PubMed ID: 1593400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts.
    Prasad P; Shuhendler A; Cai P; Rauth AM; Wu XY
    Cancer Lett; 2013 Jul; 334(2):263-73. PubMed ID: 22902994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R; Mayer LD
    Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level.
    Pepin X; Attali L; Domrault C; Gallet S; Metreau JM; Reault Y; Cardot PJ; Imalalen M; Dubernet C; Soma E; Couvreur P
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):181-91. PubMed ID: 9449570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoch-cyclosporin A induces high response rates in relapsed lymphomas.
    Lopez-Picazo JM; Gonzalez Manzano R; Ordoñez Tres JM; Jimenez MM; Calvo JP; Brugarolas A
    Haematologica; 2000 Sep; 85(9):1003-4. PubMed ID: 10980651
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.
    Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J
    Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.
    Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G
    Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.